Immunoglobulin E vaccine (Pfizer)

N/A

Report date: 2022/07/19 20:00:45

Base Information

Drug NameImmunoglobulin E vaccine (Pfizer)

Drug Alias NamePF-6444753IGE-1IGE-2PF-6444752PF-06444753 +[6]

ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine

Mechanisms of ActionImmunomodulatorsImmunoglobulin E inhibitors

TargetsImmunoglobulin E

Therapy Area/IndicationsRhinitis, Allergic

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanada

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsRhinitis, Allergic

ATC CodeN/A